Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Report 2017

世界の慢性閉塞性肺疾患用吸入薬市場:販売動向2017

◆タイトル:Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Report 2017
◆商品コード:QYR70322430
◆調査・発行会社:QYResearch
◆発行日:2017年2月6日
◆ページ数:121
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、慢性閉塞性肺疾患用吸入薬の世界市場について調査・分析し、慢性閉塞性肺疾患用吸入薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、慢性閉塞性肺疾患用吸入薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・慢性閉塞性肺疾患用吸入薬市場概要
・慢性閉塞性肺疾患用吸入薬のメーカー別販売量・メーカー別シェア
・慢性閉塞性肺疾患用吸入薬の世界市場:種類別販売量・市場シェア
・慢性閉塞性肺疾患用吸入薬の世界市場:用途別販売量・市場シェア
・慢性閉塞性肺疾患用吸入薬の世界市場:地域別販売量・市場シェア
・慢性閉塞性肺疾患用吸入薬のアメリカ市場規模
・慢性閉塞性肺疾患用吸入薬の中国市場規模
・慢性閉塞性肺疾患用吸入薬のヨーロッパ市場規模
・慢性閉塞性肺疾患用吸入薬の日本市場規模
・慢性閉塞性肺疾患用吸入薬の東南アジア市場規模
・慢性閉塞性肺疾患用吸入薬のインド市場規模
・慢性閉塞性肺疾患用吸入薬のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・慢性閉塞性肺疾患用吸入薬のコスト分析・価格動向
・慢性閉塞性肺疾患用吸入薬の産業チェーン(サプライチェーン分析)
・慢性閉塞性肺疾患用吸入薬のマーケティング戦略・販売チャネル、流通業者
・慢性閉塞性肺疾患用吸入薬市場への影響要因分析
・慢性閉塞性肺疾患用吸入薬の世界市場予測
・慢性閉塞性肺疾患用吸入薬のアメリカ市場予測
・慢性閉塞性肺疾患用吸入薬の中国市場予測
・慢性閉塞性肺疾患用吸入薬のヨーロッパ市場予測
・慢性閉塞性肺疾患用吸入薬の日本市場予測
・慢性閉塞性肺疾患用吸入薬の東南アジア市場予測
・慢性閉塞性肺疾患用吸入薬のインド市場予測
・慢性閉塞性肺疾患用吸入薬の種類別世界市場予測
・慢性閉塞性肺疾患用吸入薬の用途別世界市場予測
...

Notes:Sales, means the sales volume of Inhalers for Chronic Obstructive Pulmonary Disorder
Revenue, means the sales value of Inhalers for Chronic Obstructive Pulmonary Disorder

This report studies sales (consumption) of Inhalers for Chronic Obstructive Pulmonary Disorder in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
AstraZeneca
Boehringer Ingelheim
GSK
Novartis
Teva Pharmaceuticals
Ache Laboratorios Farmaceuticos
Almirall
Aquinox Pharmaceuticals
Ario Pharma
Asmacure
Astellas Pharma
BioMarck Pharmaceuticals
Others

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Inhalers for Chronic Obstructive Pulmonary Disorder in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Metered-Dose Inhalers (MDI’s)
Dry Powder Inhalers (DPI’s)
Soft Mist Inhalers (SMI’s)
Split by applications, this report focuses on sales, market share and growth rate of Inhalers for Chronic Obstructive Pulmonary Disorder in each application, can be divided into
GOLD 1: FEV1 ≥ 80%
GOLD 2: 50% ≤ FEV1 < 80%
GOLD 3: 30% ≤ FEV1 < 50%
GOLD 4: FEV1 < 30%

【レポートの目次】

Table of Contents

Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Report 2017
1 Inhalers for Chronic Obstructive Pulmonary Disorder Overview
1.1 Product Overview and Scope of Inhalers for Chronic Obstructive Pulmonary Disorder
1.2 Classification of Inhalers for Chronic Obstructive Pulmonary Disorder
1.2.1 Metered-Dose Inhalers (MDI’s)
1.2.2 Dry Powder Inhalers (DPI’s)
1.2.3 Soft Mist Inhalers (SMI’s)
1.3 Application of Inhalers for Chronic Obstructive Pulmonary Disorder
1.3.1 GOLD 1: FEV1 ≥ 80%
1.3.2 GOLD 2: 50% ≤ FEV1 < 80%
1.3.3 GOLD 3: 30% ≤ FEV1 < 50%
1.3.4 GOLD 4: FEV1 < 30%
1.4 Inhalers for Chronic Obstructive Pulmonary Disorder Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Inhalers for Chronic Obstructive Pulmonary Disorder (2012-2022)
1.5.1 Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2022)
1.5.2 Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)

2 Global Inhalers for Chronic Obstructive Pulmonary Disorder Competition by Manufacturers, Type and Application
2.1 Global Inhalers for Chronic Obstructive Pulmonary Disorder Market Competition by Manufacturers
2.1.1 Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Share by Manufacturers (2012-2017)
2.2 Global Inhalers for Chronic Obstructive Pulmonary Disorder (Volume and Value) by Type
2.2.1 Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type (2012-2017)
2.2.2 Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Type (2012-2017)
2.3 Global Inhalers for Chronic Obstructive Pulmonary Disorder (Volume and Value) by Regions
2.3.1 Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Regions (2012-2017)
2.3.2 Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Regions (2012-2017)
2.4 Global Inhalers for Chronic Obstructive Pulmonary Disorder (Volume) by Application

3 United States Inhalers for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
3.1 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
3.1.1 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
3.1.2 United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
3.1.3 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
3.2 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
3.3 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
3.4 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

4 China Inhalers for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
4.1 China Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
4.1.1 China Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
4.1.2 China Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
4.1.3 China Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
4.2 China Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
4.3 China Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
4.4 China Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

5 Europe Inhalers for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
5.1 Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
5.1.1 Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
5.1.2 Europe Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
5.1.3 Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
5.2 Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
5.3 Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
5.4 Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

6 Japan Inhalers for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
6.1 Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
6.1.1 Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
6.1.2 Japan Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
6.1.3 Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
6.2 Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
6.3 Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
6.4 Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application
7 Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
7.1 Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
7.1.1 Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
7.2 Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
7.3 Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
7.4 Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application
8 India Inhalers for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
8.1 India Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
8.1.1 India Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
8.1.2 India Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
8.1.3 India Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
8.2 India Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
8.3 India Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
8.4 India Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

9 Global Inhalers for Chronic Obstructive Pulmonary Disorder Manufacturers Analysis
9.1 AstraZeneca
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.1.2.1 Metered-Dose Inhalers (MDI’s)
9.1.2.2 Dry Powder Inhalers (DPI’s)
9.1.3 AstraZeneca Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Boehringer Ingelheim
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.2.2.1 Metered-Dose Inhalers (MDI’s)
9.2.2.2 Dry Powder Inhalers (DPI’s)
9.2.3 Boehringer Ingelheim Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 GSK
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.3.2.1 Metered-Dose Inhalers (MDI’s)
9.3.2.2 Dry Powder Inhalers (DPI’s)
9.3.3 GSK Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Novartis
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.4.2.1 Metered-Dose Inhalers (MDI’s)
9.4.2.2 Dry Powder Inhalers (DPI’s)
9.4.3 Novartis Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Teva Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.5.2.1 Metered-Dose Inhalers (MDI’s)
9.5.2.2 Dry Powder Inhalers (DPI’s)
9.5.3 Teva Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Ache Laboratorios Farmaceuticos
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.6.2.1 Metered-Dose Inhalers (MDI’s)
9.6.2.2 Dry Powder Inhalers (DPI’s)
9.6.3 Ache Laboratorios Farmaceuticos Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Almirall
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.7.2.1 Metered-Dose Inhalers (MDI’s)
9.7.2.2 Dry Powder Inhalers (DPI’s)
9.7.3 Almirall Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Aquinox Pharmaceuticals
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.8.2.1 Metered-Dose Inhalers (MDI’s)
9.8.2.2 Dry Powder Inhalers (DPI’s)
9.8.3 Aquinox Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Ario Pharma
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.9.2.1 Metered-Dose Inhalers (MDI’s)
9.9.2.2 Dry Powder Inhalers (DPI’s)
9.9.3 Ario Pharma Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Asmacure
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.10.2.1 Metered-Dose Inhalers (MDI’s)
9.10.2.2 Dry Powder Inhalers (DPI’s)
9.10.3 Asmacure Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Astellas Pharma
9.12 BioMarck Pharmaceuticals
9.13 Others

10 Inhalers for Chronic Obstructive Pulmonary Disorder Maufacturing Cost Analysis
10.1 Inhalers for Chronic Obstructive Pulmonary Disorder Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Inhalers for Chronic Obstructive Pulmonary Disorder
10.3 Manufacturing Process Analysis of Inhalers for Chronic Obstructive Pulmonary Disorder

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Inhalers for Chronic Obstructive Pulmonary Disorder Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Inhalers for Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Inhalers for Chronic Obstructive Pulmonary Disorder Market Forecast (2017-2022)
14.1 Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Inhalers for Chronic Obstructive Pulmonary Disorder Price and Trend Forecast (2017-2022)
14.2 Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Inhalers for Chronic Obstructive Pulmonary Disorder
Table Classification of Inhalers for Chronic Obstructive Pulmonary Disorder
Figure Global Sales Market Share of Inhalers for Chronic Obstructive Pulmonary Disorder by Type in 2015
Figure Metered-Dose Inhalers (MDI's) Picture
Figure Dry Powder Inhalers (DPI's) Picture
Figure Soft Mist Inhalers (SMI's) Picture
Table Applications of Inhalers for Chronic Obstructive Pulmonary Disorder
Figure Global Sales Market Share of Inhalers for Chronic Obstructive Pulmonary Disorder by Application in 2015
Figure GOLD 1: FEV1 ≥ 80% Examples
Figure GOLD 2: 50% ≤ FEV1 < 80% Examples
Figure GOLD 3: 30% ≤ FEV1 < 50% Examples
Figure GOLD 4: FEV1 < 30% Examples
Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure China Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Europe Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Japan Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure India Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2022)
Figure Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales of Key Manufacturers (2012-2017)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers (2012-2017)
Figure 2015 Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers
Figure 2016 Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue by Manufacturers (2012-2017)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers
Table 2016 Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type (2012-2017)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share by Type (2012-2017)
Figure Sales Market Share of Inhalers for Chronic Obstructive Pulmonary Disorder by Type (2012-2017)
Figure Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Type (2012-2017)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Type (2012-2017)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Inhalers for Chronic Obstructive Pulmonary Disorder by Type (2012-2017)
Figure Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Growth Rate by Type (2012-2017)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Regions (2012-2017)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share by Regions (2012-2017)
Figure Sales Market Share of Inhalers for Chronic Obstructive Pulmonary Disorder by Regions (2012-2017)
Figure Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Regions (2012-2017)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Regions (2012-2017)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Inhalers for Chronic Obstructive Pulmonary Disorder by Regions (2012-2017)
Figure Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Growth Rate by Regions (2012-2017)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application (2012-2017)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share by Application (2012-2017)
Figure Sales Market Share of Inhalers for Chronic Obstructive Pulmonary Disorder by Application (2012-2017)
Figure Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Application (2012-2017)
Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Figure China Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure China Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure China Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table China Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table China Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table China Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table China Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table China Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table China Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Figure Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure Europe Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table Europe Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table Europe Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table Europe Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table Europe Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Figure Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure Japan Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table Japan Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table Japan Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table Japan Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table Japan Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Figure Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table Southeast Asia Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Figure India Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure India Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure India Inhalers for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table India Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2012-2017)
Table India Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2012-2017)
Table India Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)
Table India Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Type (2012-2017)
Table India Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)
Table India Inhalers for Chronic Obstructive Pulmonary Disorder Market Share by Application (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Inhalers for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Inhalers for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Inhalers for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Inhalers for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Teva Pharmaceuticals Basic Information List
Table Teva Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Ache Laboratorios Farmaceuticos Basic Information List
Table Ache Laboratorios Farmaceuticos Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ache Laboratorios Farmaceuticos Inhalers for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Almirall Basic Information List
Table Almirall Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Almirall Inhalers for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Aquinox Pharmaceuticals Basic Information List
Table Aquinox Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Aquinox Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Ario Pharma Basic Information List
Table Ario Pharma Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ario Pharma Inhalers for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Asmacure Basic Information List
Table Asmacure Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Asmacure Inhalers for Chronic Obstructive Pulmonary Disorder Global Market Share (2012-2017)
Table Astellas Pharma Basic Information List
Table BioMarck Pharmaceuticals Basic Information List
Table Others Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Inhalers for Chronic Obstructive Pulmonary Disorder
Figure Manufacturing Process Analysis of Inhalers for Chronic Obstructive Pulmonary Disorder
Figure Inhalers for Chronic Obstructive Pulmonary Disorder Industrial Chain Analysis
Table Raw Materials Sources of Inhalers for Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2015
Table Major Buyers of Inhalers for Chronic Obstructive Pulmonary Disorder
Table Distributors/Traders List
Figure Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
Figure Global Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Forecast by Regions (2017-2022)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Forecast by Type (2017-2022)
Table Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Forecast by Application (2017-2022)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の慢性閉塞性肺疾患用吸入薬市場:販売動向2017] (Global Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Report 2017 / QYR70322430)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆